e-learning
resources
Munich 2006
Tuesday 05.09.2006
Recent advances in the treatment of asthma and allergic rhinitis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adrenal crisis and hypercorticism induced by inhaled corticosteroids
M. Molimard, C. Pollet, A. Abouelfath, A. Fourrier, F. Haramburu, N. Moore, M. Fayon, A. Tabarin (Bordeaux, France)
Source:
Annual Congress 2006 - Recent advances in the treatment of asthma and allergic rhinitis
Session:
Recent advances in the treatment of asthma and allergic rhinitis
Session type:
Thematic Poster Session
Number:
3860
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Molimard, C. Pollet, A. Abouelfath, A. Fourrier, F. Haramburu, N. Moore, M. Fayon, A. Tabarin (Bordeaux, France). Adrenal crisis and hypercorticism induced by inhaled corticosteroids. Eur Respir J 2006; 28: Suppl. 50, 3860
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids
Source: Eur Respir J 2008; 32: 1047-1052
Year: 2008
Adrenal function with low acth doses in asthmatic children with inhaled corticosteroids
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
The use of inhaled corticosteroids and the risk of adrenal insufficiency
Source: Eur Respir J 2013; 42: 79-86
Year: 2013
Adrenal insufficiency in asthma treated with high/low systemic corticosteroids in the past and in those who sucessfully discontinued systemic corticosteroids after treatment with omalizmab.
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017
Adrenal function improvement of most asthmatic children on inhaled corticosteroids
Source: Eur Respir J 2006; 28: Suppl. 50, 260s
Year: 2006
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
Source: Eur Respir J 2004; 23: 354-355
Year: 2004
Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005
Getting risks right on inhaled corticosteroids and adrenal insufficiency
Source: Eur Respir J 2013; 42: 9-11
Year: 2013
Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
Inhaled steroids in children: adrenal suppression and growth impairment
Source: Eur Respir J 2002; 19: 985-988
Year: 2002
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β
2
agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010
Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma
Source: Eur Respir J 2003; 21: 633-636
Year: 2003
Inhaled corticosteroids and adrenal insufficiency: a case-control study
Source: Eur Respir J 2005; 26: Suppl. 49, 220s
Year: 2005
Adrenal suppression in children using inhaled corticosteroids: neither recommended nor presribed doses identify those at risk
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004
Inhaled corticosteroids as a cause of CAP
Source: Eur Respir Monogr 2014; 63: 234-242
Year: 2014
Radiation pneumonitis in an infant treated with systemic and inhaled steroids
Source: Eur Respir J 2006; 28: Suppl. 50, 90s
Year: 2006
Inhaled steroids in the treatment of newly detected asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004
Mechanisms of systemic side effects of inhaled steroids
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004
Inhaled steroids and COPD
Source: Eur Respir J 2008; 32: 523-524
Year: 2008
Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids
Source: Eur Respir J 2016; 48: 558-560
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept